Dilip Sanghvi topples mukesh ambani to become richest indian

[Diggy]

Sun Pharma’s Dilip Shanghvi on Wednesday toppled Reliance Industries chief Mukesh Ambani as India’s richest person, with the shares of Sun Pharma and Sun Pharma Advanced Research Company, or Sparc (Sun Pharma’s research and development arm), closing at record highs.

At current prices, Shanghvi is valued at Rs 1.39 lakh crore ($22.4 billion), while Ambani is worth Rs 1.38 lakh crore ($22.2 billion).

Shanghvi’s value will be higher if Sun’s Suzlon Energy and Ranbaxy acquisitions are factored in.

However, as the deals are yet to be closed, Shanghvi’s holdings in these entities, valued at about Rs 22,000 crore (Rs 220 billion), haven’t been considered.

In the past year, Shanghvi, the founder and managing director of India’s largest drug maker, has seen his wealth rise 65 per cent, while the valuation of Mukesh Ambani, India’s richest for the past eight years, has increased only 11 per cent.

On Wednesday, the Sun Pharma and Sparc stocks rose 6.6 per cent and 4.6 per cent, respectively, with the company securing a nod for an antiepileptic drug from the US drug regulator. The Reliance Industries stock lost 1.63 per cent.

Sun Pharma’s market capitalisation stands at Rs 2.08 lakh crore, while that of Sparc is about Rs 10,200 crore (Rs 102 billion); Reliance Industries’ market value is Rs 2.86 lakh crore.

The promoter holding in Sun Pharma is valued at Rs 1.32 lakh crore, while that in Reliance Industries is worth Rs 1.30 lakh crore.

The Sun Pharma group’s market value in Ranbaxy Laboratories is valued at Rs 21,048 crore (Rs 210.48 billion), while its 23 per cent stake in Suzlon is worth Rs 2,055 crore (Rs 20.55 billion).

Last year, the drug marker had acquired rival firm Ranbaxy in an all-share deal. Recently, Sun Pharma founders had announced they were acquiring 23 per cent stake in wind turbine maker Suzlon.

http://www.rediff.com/business/report/pix-dilip-shanghvi-pips-mukesh-ambani-as-richest-indian
/20150305.htm




Sun pharma is the next big thing to watch out guys , i have bought sun pharma shares and it has been continuously rising since its deal with ranbaxy (one of the few stocks in my portfolio where i made some money) , members are suggested to buy sun pharma shares as it will breach new levels.

Isn't it good if mukesh ambani is toppled by someone else as the biggest business tycoon in india , i mean wouldn't it be good for relaince itself as bcz he has been at the top for a very long time and has become the prime target for many attention seekers karantikari netas like kejrwal , RIL has been engulfed in so many problems , check out its share price , hardly any movement. If the attention gets diverted somewhere else it would give mukesh ambani the much needed space to work.


@SrNair @GURU DUTT @anant_s @Chanakya's_Chant @TejasMk3 @wolfschanzze

 

[wolfschanzze]

Indian Pharma companies are making a good profit, no wonder west is whining about generic drugs.

 

[Diggy]

Indian Pharma companies are making a good profit, no wonder west is whining about generic drugs.

pharma sector is poised for growth mate , there will be no decrease in demand for medicines in a country like india

lupin , cipla , Dr reddy are some other stocks you should watch out

biocon has been working on some oral insulin project , if that works it would be a game changer for them

i remember Dr reddy faced some probs in the US

 

[wolfschanzze]

pharma sector is poised for growth mate , there will be no decrease in demand for medicines in a country like india

lupin , cipla , Dr reddy are some other stocks you should watch out

biocon has been working on some oral insulin project , if that works it would be a game changer for them

i remember Dr reddy faced some probs in the US

With "Make in India",The infrastructure for growth in Pharma Sector will be even more,West cannot complain then about Indian pharma companies not meeting Western standards.

 

[SrNair]

Reduction in oil prices kicked out Mukesh Ambani from top position.Pharmecueticals would be way better than the oil in future.

 

[Chanakya's_Chant]

Sun Pharma’s Dilip Shanghvi on Wednesday toppled Reliance Industries chief Mukesh Ambani as India’s richest person, with the shares of Sun Pharma and Sun Pharma Advanced Research Company, or Sparc (Sun Pharma’s research and development arm), closing at record highs.

At current prices, Shanghvi is valued at Rs 1.39 lakh crore ($22.4 billion), while Ambani is worth Rs 1.38 lakh crore ($22.2 billion).

Shanghvi’s value will be higher if Sun’s Suzlon Energy and Ranbaxy acquisitions are factored in.

However, as the deals are yet to be closed, Shanghvi’s holdings in these entities, valued at about Rs 22,000 crore (Rs 220 billion), haven’t been considered.

In the past year, Shanghvi, the founder and managing director of India’s largest drug maker, has seen his wealth rise 65 per cent, while the valuation of Mukesh Ambani, India’s richest for the past eight years, has increased only 11 per cent.

On Wednesday, the Sun Pharma and Sparc stocks rose 6.6 per cent and 4.6 per cent, respectively, with the company securing a nod for an antiepileptic drug from the US drug regulator. The Reliance Industries stock lost 1.63 per cent.

Sun Pharma’s market capitalisation stands at Rs 2.08 lakh crore, while that of Sparc is about Rs 10,200 crore (Rs 102 billion); Reliance Industries’ market value is Rs 2.86 lakh crore.

The promoter holding in Sun Pharma is valued at Rs 1.32 lakh crore, while that in Reliance Industries is worth Rs 1.30 lakh crore.

The Sun Pharma group’s market value in Ranbaxy Laboratories is valued at Rs 21,048 crore (Rs 210.48 billion), while its 23 per cent stake in Suzlon is worth Rs 2,055 crore (Rs 20.55 billion).

Last year, the drug marker had acquired rival firm Ranbaxy in an all-share deal. Recently, Sun Pharma founders had announced they were acquiring 23 per cent stake in wind turbine maker Suzlon.

http://www.rediff.com/business/report/pix-dilip-shanghvi-pips-mukesh-ambani-as-richest-indian
/20150305.htm




Sun pharma is the next big thing to watch out guys , i have bought sun pharma shares and it has been continuously rising since its deal with ranbaxy (one of the few stocks in my portfolio where i made some money) , members are suggested to buy sun pharma shares as it will breach new levels.

Isn't it good if mukesh ambani is toppled by someone else as the biggest business tycoon in india , i mean wouldn't it be good for relaince itself as bcz he has been at the top for a very long time and has become the prime target for many attention seekers karantikari netas like kejrwal , RIL has been engulfed in so many problems , check out its share price , hardly any movement. If the attention gets diverted somewhere else it would give mukesh ambani the much needed space to work.


@SrNair @GURU DUTT @anant_s @Chanakya's_Chant @TejasMk3 @wolfschanzze

Mukesh Ambami is a damn corrupt businessman - it's an open secret! It's always great to see "self made" billionaires who built their enterprises all by themselves! Dilip Sanghavi started Sun Pharmaceutical Industries with capital of Rs 10,000 in 1982 at Vapi and look now where he stands! People like him inspire others to walk the road less traveled by!

 

[anant_s]

Pharmaceutical sector is the next big thing and with more and more companies putting more resources in r&d, next billionaires would come from this sector.
I hope these pharmacy moguls put some of their wealth towards philanthropy and help in developing cheaper generic drugs which would be great service to the society.